These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24163121)

  • 1. Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug-eluting stent implantation.
    Xu X; Zhou Y; Luo S; Zhang W; Zhao Y; Yu M; Ma Q; Gao F; Shen H; Zhang J
    Angiology; 2014 Sep; 65(8):660-6. PubMed ID: 24163121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation.
    Luo SJ; Zhou YJ; Shi DM; Ge HL; Wang JL; Liu RF
    Can J Cardiol; 2013 Sep; 29(9):1084-9. PubMed ID: 23414904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
    Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
    Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention.
    Ahmed RM; Mohamed el-HA; Ashraf M; Maithili S; Nabil F; Rami R; Mohamed TI
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E647-53. PubMed ID: 23404916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and angiographic outcome in coronary artery disease patients with type-II diabetes mellitus undergoing elective bare-metal stenting or drug-eluting stenting].
    Qiao SB; Hou Q; Xu B; Chen J; Liu HB; Yang YJ; Wu YJ; Yuan JQ; Wu Y; Dai J; You SJ; Ma WH; Zhang P; Gao Z; Dou KF; Qiu H; Mu CW; Chen JL; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):523-6. PubMed ID: 17711711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials.
    Pei H; Wu Y; Wei Y; Yang Y; Teng S; Zhang H
    PLoS One; 2014; 9(12):e115500. PubMed ID: 25551671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials.
    D'Ascenzo F; Moretti C; Omedè P; Cerrato E; Cavallero E; Er F; Presutti DG; Colombo F; Crimi G; Conrotto F; Dinicolantonio JJ; Chen S; Prasad A; Biondi Zoccai G; Gaita F
    EuroIntervention; 2014; 9(12):1463-71. PubMed ID: 24755386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
    Zografos TA; Katritsis GD; Tsiafoutis I; Bourboulis N; Katsivas A; Katritsis DG
    Am J Cardiol; 2014 Jun; 113(12):2013-7. PubMed ID: 24793669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote ischemic preconditioning in percutaneous coronary revascularization: a double-blind randomized controlled clinical trial.
    Ghaemian A; Nouraei SM; Abdollahian F; Naghshvar F; Giussani DA; Nouraei SA
    Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):548-54. PubMed ID: 23087298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease.
    Sheiban I; Garrone P; Sillano D; Biondi-Zoccai G; Sciuto F; Omedè P; Lombardi P; Meliga E; Anselmino M; Trevi GP; Moretti C
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1246-53. PubMed ID: 19001932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials.
    Vardi M; Burke DA; Bangalore S; Pencina MJ; Mauri L; Kandzari DE; Leon MB; Cutlip DE
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1031-8. PubMed ID: 23737390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease.
    Niccoli G; Sgueglia GA; Cosentino N; Piro M; Toma A; Cataneo L; Fracassi F; Porto I; Leone AM; Burzotta F; Trani C; Crea F
    Eur J Prev Cardiol; 2012 Oct; 19(5):914-26. PubMed ID: 21840968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Gordon PC; Cohen DJ; Kleiman NS; Montgomery JA; Semder CA; Kennedy KF; Keyes MJ; Piana RN;
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E356-64. PubMed ID: 22511502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
    Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
    Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary intervention.
    Hoole SP; Heck PM; White PA; Khan SN; O'Sullivan M; Clarke SC; Dutka DP
    Angiology; 2009; 60(4):403-11. PubMed ID: 19106155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.